Cargando…

Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer

INTRODUCTION: Adjuvant treatment with tamoxifen substantially improves survival of women with estrogen-receptor positive (ER+) tumors. Tamoxifen resistance (TAMR) limits clinical benefit. RRR-α-tocopherol ether-linked acetic acid analogue (α-TEA) is a small bioactive lipid with potent anticancer act...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiwary, Richa, Yu, Weiping, deGraffenried, Linda A, Sanders, Bob G, Kline, Kimberly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326562/
https://www.ncbi.nlm.nih.gov/pubmed/22115051
http://dx.doi.org/10.1186/bcr3063
_version_ 1782229530944995328
author Tiwary, Richa
Yu, Weiping
deGraffenried, Linda A
Sanders, Bob G
Kline, Kimberly
author_facet Tiwary, Richa
Yu, Weiping
deGraffenried, Linda A
Sanders, Bob G
Kline, Kimberly
author_sort Tiwary, Richa
collection PubMed
description INTRODUCTION: Adjuvant treatment with tamoxifen substantially improves survival of women with estrogen-receptor positive (ER+) tumors. Tamoxifen resistance (TAMR) limits clinical benefit. RRR-α-tocopherol ether-linked acetic acid analogue (α-TEA) is a small bioactive lipid with potent anticancer activity. We evaluated the ability of α-TEA in the presence of tamoxifen to circumvent TAMR in human breast cancer cell lines. METHODS: Two genotypically matched sets of TAM-sensitive (TAMS) and TAM-resistant (TAMR) human breast cancer cell lines were assessed for signal-transduction events with Western blotting, apoptosis induction with Annexin V-FITC/PI assays, and characterization of cholesterol-rich microdomains with fluorescence staining. Critical involvement of selected mediators was determined by using RNA interference and chemical inhibitors. RESULTS: Growth-factor receptors (total and phosphorylated forms of HER-1 and HER-2), their downstream prosurvival mediators pAkt, pmTOR, and pERK1/2, phosphorylated form of estrogen receptor-α (pER-α at Ser-167 and Ser-118, and cholesterol-rich lipid microdomains were highly amplified in TAMR cell lines and enhanced by treatment with TAM. α-TEA disrupted cholesterol-rich microdomains, acted cooperatively with TAM to reduce prosurvival mediators, and induced DR5-mediated mitochondria-dependent apoptosis via an endoplasmic reticulum stress-triggered pro-death pJNK/CHOP/DR5 amplification loop. Furthermore, methyl-β-cyclodextrin (MβCD), a chemical disruptor of cholesterol rich microdomains, acted cooperatively with TAM to reduce prosurvival mediators and to induce apoptosis. CONCLUSIONS: Data for the first time document that targeting cholesterol-rich lipid microdomains is a potential strategy to circumvent TAMR, and the combination of α-TEA + TAM can circumvent TAMR by suppression of prosurvival signaling via disruption of cholesterol-rich lipid microdomains and activation of apoptotic pathways via induction of endoplasmic reticulum stress.
format Online
Article
Text
id pubmed-3326562
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33265622012-04-16 Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer Tiwary, Richa Yu, Weiping deGraffenried, Linda A Sanders, Bob G Kline, Kimberly Breast Cancer Res Research Article INTRODUCTION: Adjuvant treatment with tamoxifen substantially improves survival of women with estrogen-receptor positive (ER+) tumors. Tamoxifen resistance (TAMR) limits clinical benefit. RRR-α-tocopherol ether-linked acetic acid analogue (α-TEA) is a small bioactive lipid with potent anticancer activity. We evaluated the ability of α-TEA in the presence of tamoxifen to circumvent TAMR in human breast cancer cell lines. METHODS: Two genotypically matched sets of TAM-sensitive (TAMS) and TAM-resistant (TAMR) human breast cancer cell lines were assessed for signal-transduction events with Western blotting, apoptosis induction with Annexin V-FITC/PI assays, and characterization of cholesterol-rich microdomains with fluorescence staining. Critical involvement of selected mediators was determined by using RNA interference and chemical inhibitors. RESULTS: Growth-factor receptors (total and phosphorylated forms of HER-1 and HER-2), their downstream prosurvival mediators pAkt, pmTOR, and pERK1/2, phosphorylated form of estrogen receptor-α (pER-α at Ser-167 and Ser-118, and cholesterol-rich lipid microdomains were highly amplified in TAMR cell lines and enhanced by treatment with TAM. α-TEA disrupted cholesterol-rich microdomains, acted cooperatively with TAM to reduce prosurvival mediators, and induced DR5-mediated mitochondria-dependent apoptosis via an endoplasmic reticulum stress-triggered pro-death pJNK/CHOP/DR5 amplification loop. Furthermore, methyl-β-cyclodextrin (MβCD), a chemical disruptor of cholesterol rich microdomains, acted cooperatively with TAM to reduce prosurvival mediators and to induce apoptosis. CONCLUSIONS: Data for the first time document that targeting cholesterol-rich lipid microdomains is a potential strategy to circumvent TAMR, and the combination of α-TEA + TAM can circumvent TAMR by suppression of prosurvival signaling via disruption of cholesterol-rich lipid microdomains and activation of apoptotic pathways via induction of endoplasmic reticulum stress. BioMed Central 2011 2011-11-24 /pmc/articles/PMC3326562/ /pubmed/22115051 http://dx.doi.org/10.1186/bcr3063 Text en Copyright ©2011 Tiwary et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Tiwary, Richa
Yu, Weiping
deGraffenried, Linda A
Sanders, Bob G
Kline, Kimberly
Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer
title Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer
title_full Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer
title_fullStr Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer
title_full_unstemmed Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer
title_short Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer
title_sort targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326562/
https://www.ncbi.nlm.nih.gov/pubmed/22115051
http://dx.doi.org/10.1186/bcr3063
work_keys_str_mv AT tiwaryricha targetingcholesterolrichmicrodomainstocircumventtamoxifenresistantbreastcancer
AT yuweiping targetingcholesterolrichmicrodomainstocircumventtamoxifenresistantbreastcancer
AT degraffenriedlindaa targetingcholesterolrichmicrodomainstocircumventtamoxifenresistantbreastcancer
AT sandersbobg targetingcholesterolrichmicrodomainstocircumventtamoxifenresistantbreastcancer
AT klinekimberly targetingcholesterolrichmicrodomainstocircumventtamoxifenresistantbreastcancer